NEXGEL, Inc. (NXGLW) stock

NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $34.21MP/E –Yield –

Nexgel price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nexgel's price to book ratio was 11.4× on Oct 19, 2026, against 80.6× a year earlier. Over the last 5 years it ranged from 6.8× to 327.2×, with a median of 42.7×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	11.4×	−39.2
2025	Dec 31, 2025	50.6×	−78.7
2024	Dec 31, 2024	129.2×	+86.5
2023	Dec 29, 2023	42.7×	+25.8
2022	Dec 30, 2022	17.0×	−304.4
2021	Dec 31, 2021	321.3×	–

Where these numbers come from

Parsed from the XBRL in Nexgel's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Oct 12, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NXGLW.

Compare: NXGLW vs SNOA · NXGLW vs NEPH · NXGLW vs SRTS · NXGLW vs MDNC · NXGLW vs NSPR

Revenue growth3.4% · median 24.2%

Gross margin35.1% · median 38.9%

Operating margin-44.8% · median -6.4%

Net margin-51.3% · median -10.3%

Company	Revenue	Growth
SNOA	$21.92M	+47.0%
NEPH	$20.72M	+24.2%
SRTS	$17.51M	-53.4%
NXGLW	$12.07M	+3.4%
NSPR	$10.84M	+53.4%
MDNC	$10.21M	-10.9%

Company

Next earnings (est.): Nov 11, 2026, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 19
Auditor: Turner, Stone & Company, L.L.P.
SEC CIK: 1468929

Advertisement
300 × 250